Herbal Medicine to Treat ALS, Syrinx, MS, MD and MG
Amyotrophic lateral sclerosis (ALS), Myasthenia gravis (MG), syringomyelia (SM, also called syrinx, hydromyelia, syringohydromyelia), progressive spinal muscular atrophy (SMA), progressive atrophy, facial paralysis, polyneuritis, multiple sclerosis (MS), etc, are disorders belonging to the category of myelopathy and muscular atrophy. They are very complicated diseases and still remains the difficulties when resorting to approach to solve them. Thus for long time tremendous efforts had been made to find a solution world wide.
Dr. Huai Yuanming, the senior research professor with Hebei TCM College, has made continued efforts for as long as 20 years with the aim to find a possible solution for curing these diseases. In 1987, he began to introduce one herbal medicine series treating myolopathy and muscular atrophy. After another three years of clinical experiments and formula ingredients changes and adaption, he gradually found a more reasonable formula composition and the effective rate increase a lot. Such continuous changes and improvements never stop and gradually the main medicine series came into formation.
In 1986, under the leadership by Dr. Huai Yuanming the GhangCheng Myelophathy Hospital was set up to professionally treat the illness and carry out more research work to the mechanism of the diseases. Now in China, GhangCheng Myelopathy Hospital continuously plays the leading role in applying traditional Chinese herbal medicine in the field of myelopathy treatment and has gained prominent standing.
During the long time of clinical experiments and research Dr. Huai and his colleagues gradually found that the Amyotrophy Convalescence Pill Series can not cope with patients’ diverse conditions in a very ideal way. So, they developed the medicine into 5 kinds, verified to be wildly adapted to different practical conditions and the effective rate (ie,improvement rate) for syringomyelia can be as high as 91.50%, the effective rate for amyotrophic lateral sclerosis (ALS) is 86.9%, the effective rate (improvement rate) for progressive spinal muscular atrophy(SMA) is 77.3%, the improvement rate for myasthenia gravis (MG) is 89%, the effective rate for muscular dystrophies (MD) can be 84.9%. In a word, the different medicine combination versions can fully be adapted for treating various disorders in the category of myolopathy and muscular atrophy.
Effective rate means the percentage of patients who show improvement among all patients who receive the same treatment. More than around 4,470 out-patients and more than a 920 in-patients who were all ill with myelopathy or muscular atrophy had been treated in the hospital from 1987 to December 2004.
By assay and experimental means such as the radiation immunology, histochemistry, electron microscope, immunoenzyme method and stereology several medicine institutes had carried out pharmacological mechanism research to the Amyotrophy Convalescence Pill Series medicine. The conclusion indicates that the medicine can promote the assimilation of hydrocrania, reverse the degeneration of bone marrow confine, reduce the intramedullary cavity, and secure the well being of neurotransmitter.
Dr. Huai Yuanming was born to a family who has a career in the field Chinese herbal medicine. His father was once very famous in China in 1940’s and left with Chinese herbal medicine theory a treasure of new theory school. Such school of herbal medicine had profund impact upon the contemporary herbal medicine system. Later, due to the influence from his fater from childhood, he began to show strong interest in traditional medicine and later he studied in Beijing TCM College. Now aged 57 Dr. Huai Yuanming served as the director of Gangcheng Myelopathy Hospital.
Now, in Gangcheng Myelopathy Hospital there are out-patient department, common sickrooms, senior sickrooms. Their medicine include capsule, granule, decoction. Other treatment methods such as Chinese acupuncture, effective component ion importation, Chinese Chi Kung, are also introduced. For more information regarding Amyotrophy Convalescence Pill Series please CLICK HERE.